Skip to main content
. Author manuscript; available in PMC: 2022 Nov 15.
Published in final edited form as: J Immunol. 2021 Oct 4;207(10):2598–2607. doi: 10.4049/jimmunol.2001334

Table I.

Genes significantly regulated in Tregs treated with PD-1 blockade versus untreated.i

Upregulated
Gene baseMean Log2FoldChange padj
Klf2 1351.561 1.473 5.55E-16
Jun 1034.796 0.984 1.86E-07
Rhob 300.810 1.230 2.31E-05
Ubc 5773.062 0.635 0.0004
S1pr1 1512.735 0.629 0.0016
Fos 809.493 0.788 0.0016
Ier2 646.815 0.774 0.0083
Adrb2 328.347 0.830 0.0088
Klf3 254.169 0.903 0.0104
Atp1b1 72.096 1.011 0.0221
Tsc22d3 942.382 0.746 0.0221
Bcl2 203.146 0.940 0.0288
Snord17 5426.186 0.630 0.0319
Card6 481.202 0.731 0.0350
Downregulated
Gene baseMean Log2FoldChange padj
Arl5a 5260.143 −0.655 0.0003
Sypl 553.684 −0.809 0.0016
Ccr5 652.223 −0.732 0.0016
Ltf 48.023 −1.069 0.0092
Itgb8 972.937 −0.662 0.0152
Gcnt1 300.171 −0.797 0.0220
Klrg1 370.393 −0.712 0.0499
i

Foxp3-GFP mice were injected with 1 × 104 T11 (claudin-low) cells and were untreated or treated with 200μg α-PD1 antibody (J43) injected IP twice a week. Tumors were harvested at 150 mm2, digested, enriched for lymphocytes, and GFP+ Tregs were sorted to greater than 90% purity using MoFlo XDP cell sorter. RNA was isolated from sorted cells and RNA-Seq was performed on the HiSeq 2500 Rapid Run platform. (n=6) Differential gene-expression analysis was performed using DESeq2. Genes listed are significantly upregulated or downregulated with an adjusted p value < 0.5.